A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors (Q33209343)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors
scientific article

    Statements

    A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors (English)
    van der Gaast A
    Sparreboom A
    van der Burg ME
    de Boer-Dennert M
    Purvis NB Jr

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit